Literature DB >> 19184660

Pharmacotherapy for tobacco dependence.

Reginald V Fant1, August R Buchhalter, Albert C Buchman, Jack E Henningfield.   

Abstract

Pharmacotherapy can provide effective treatment of tobacco dependence and withdrawal, and thereby facilitate efforts to achieve and sustain tobacco abstinence. Currently approved medications for smoking cessation are nicotine replacement medications (NRT), including nicotine patch, gum, lozenge, sublingual tablet, inhaler and nasal spray, the antidepressant bupropion, and the nicotinic partial agonist varenicline. This review discusses the pharmacological basis for the use of these medications, and the properties that might contribute to their efficacy, safety, and abuse liability. The review also discusses how pharmacological principles can be used to improve existing medications, as well as assist in the development of new medications.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19184660     DOI: 10.1007/978-3-540-69248-5_17

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  13 in total

1.  Separate and combined effects of gabapentin and [INCREMENT]9-tetrahydrocannabinol in humans discriminating [INCREMENT]9-tetrahydrocannabinol.

Authors:  Joshua A Lile; Michael J Wesley; Thomas H Kelly; Lon R Hays
Journal:  Behav Pharmacol       Date:  2016-04       Impact factor: 2.293

Review 2.  Role of progesterone in nicotine addiction: evidence from initiation to relapse.

Authors:  Wendy J Lynch; Mehmet Sofuoglu
Journal:  Exp Clin Psychopharmacol       Date:  2010-12       Impact factor: 3.157

3.  Treatment for tobacco dependence: effect on brain nicotinic acetylcholine receptor density.

Authors:  Arthur L Brody; Alexey G Mukhin; Michael S Mamoun; Maggie Kozman; Jonathan Phuong; Meaghan Neary; Trinh Luu; Mark A Mandelkern
Journal:  Neuropsychopharmacology       Date:  2013-02-21       Impact factor: 7.853

4.  Nicotine exposure and metabolizer phenotypes from analysis of urinary nicotine and its 15 metabolites by LC-MS.

Authors:  Kannan Rangiah; Wei-Ting Hwang; Clementina Mesaros; Anil Vachani; Ian A Blair
Journal:  Bioanalysis       Date:  2011-04       Impact factor: 2.681

5.  Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.

Authors:  F Ivy Carroll; Bruce E Blough; S Wayne Mascarella; Hernán A Navarro; J Brek Eaton; Ronald J Lukas; M Imad Damaj
Journal:  J Med Chem       Date:  2010-03-11       Impact factor: 7.446

6.  Double target concept for smoking cessation.

Authors:  Jie Wu
Journal:  Acta Pharmacol Sin       Date:  2010-08-16       Impact factor: 6.150

7.  Positive allosteric modulation of α4β2 nicotinic acetylcholine receptors as a new approach to smoking reduction: evidence from a rat model of nicotine self-administration.

Authors:  Xiu Liu
Journal:  Psychopharmacology (Berl)       Date:  2013-05-28       Impact factor: 4.530

Review 8.  Pharmacotherapy for smoking cessation: pharmacological principles and clinical practice.

Authors:  Henri-Jean Aubin; Amandine Luquiens; Ivan Berlin
Journal:  Br J Clin Pharmacol       Date:  2014-02       Impact factor: 4.335

9.  Pharmacologic agents for smoking cessation: a clinical review.

Authors:  Dilip R Patel; Cynthia Feucht; Lesley Reid; Neil D Patel
Journal:  Clin Pharmacol       Date:  2010-04-07

10.  Brief Arabic tobacco craving questionnaire: An investigation into craving and heavy smoking in Saudi Arabian males.

Authors:  Abdulaziz A Albrithen; Edward G Singleton
Journal:  J Family Community Med       Date:  2015 Jan-Apr
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.